BBIO

SEC source: 0001470831-26-000897 · wk-form4_1790029286.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 495,686

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F4 · price: Represents the weighted average sale price of the shares sold from $69.525 to $69.64 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0001470831-26-000897 · wk-form4_1790029286.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 496,965

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F2 · price: Represents the weighted average sale price of the shares sold from $68.52 to $69.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0001470831-26-000848 · wk-form4_1787257884.xml · nonDerivative · entry 7

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 505,686

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F7 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0001470831-26-000848 · wk-form4_1787257884.xml · nonDerivative · entry 6

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 505,786

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F8 · price: Represents the weighted average sale price of the shares sold from $84.35 to $85.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F7 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0001470831-26-000848 · wk-form4_1787257884.xml · nonDerivative · entry 5

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 507,586

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F6 · price: Represents the weighted average sale price of the shares sold from $83.34 to $84.31 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F7 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0001470831-26-000848 · wk-form4_1787257884.xml · nonDerivative · entry 4

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 243,327

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F5 · price: Represents the weighted average sale price of the shares sold from $83.65 to $83.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0001470831-26-000848 · wk-form4_1787257884.xml · nonDerivative · entry 3

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 244,526

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F4 · price: Represents the weighted average sale price of the shares sold from $82.62 to $83.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0001470831-26-000848 · wk-form4_1787257884.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 259,128

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F3 · price: Represents the weighted average sale price of the shares sold from $81.62 to $82.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0001470831-26-000848 · wk-form4_1787257884.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 276,407

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.

F2 · price: Represents the weighted average sale price of the shares sold from $80.54 to $81.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0001470831-26-000835 · wk-form4_1787090542.xml · nonDerivative · entry 1

Apuli Maricel · CIK 0002058197 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,687

F1 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,262 shares of Common Stock underlying the Reporting Person's RSUs.

SEC source: 0001470831-26-000837 · wk-form4_1787090557.xml · nonDerivative · entry 1

Trimarchi Thomas · CIK 0002030813 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,529

F1 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 41,194 shares of Common Stock underlying the Reporting Person's RSUs.

F2 · balance_after: Includes 116 shares of the Issuer's Common Stock acquired by the Reporting Person on August 14, 2026 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · derivative · entry 12

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,274

Underlying: Common Stock · 6,520 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F9 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2026. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F9 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2026. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · derivative · entry 11

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,538

Underlying: Common Stock · 11,554 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F8 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F8 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · derivative · entry 10

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,596

Underlying: Common Stock · 19,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F7 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F7 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · derivative · entry 9

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,088

Underlying: Common Stock · 33,544 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F6 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F6 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · nonDerivative · entry 5

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 278,307

F2 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 71,217 shares of Common Stock underlying the Reporting Person's RSUs.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · nonDerivative · entry 4

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · nonDerivative · entry 3

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0001470831-26-000836 · wk-form4_1787090549.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0001470831-26-000745 · wk-form4_1785788451.xml · nonDerivative · entry 1

Apuli Maricel · CIK 0002058197 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,401

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.

SEC source: 0001470831-26-000709 · wk-form4_1783975290.xml · derivative · entry 3

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,167

Underlying: Common Stock · 17,167 shares

Expires 2033-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025.

F2 · derivative.exercise_date: 1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.

SEC source: 0001470831-26-000709 · wk-form4_1783975290.xml · nonDerivative · entry 2

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,579

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025.

SEC source: 0001470831-26-000709 · wk-form4_1783975290.xml · nonDerivative · entry 1

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,746

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025.

SEC source: 0001470831-26-000708 · wk-form4_1783975232.xml · derivative · entry 8

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,167 shares

Expires 2033-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

F4 · derivative.exercise_date: 1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.

SEC source: 0001470831-26-000708 · wk-form4_1783975232.xml · derivative · entry 7

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 112,422 shares

Expires 2030-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

SEC source: 0001470831-26-000708 · wk-form4_1783975232.xml · derivative · entry 6

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires 2032-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

F2 · derivative.exercise_date: 1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company.

SEC source: 0001470831-26-000708 · wk-form4_1783975232.xml · nonDerivative · entry 5

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,383

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000708 · wk-form4_1783975232.xml · nonDerivative · entry 4

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,805

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000708 · wk-form4_1783975232.xml · nonDerivative · entry 3

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000708 · wk-form4_1783975232.xml · nonDerivative · entry 2

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000708 · wk-form4_1783975232.xml · nonDerivative · entry 1

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,383

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000636 · wk-form4_1782338786.xml · derivative · entry 8

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,167

Underlying: Common Stock · 17,167 shares

Expires 2033-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

F6 · derivative.exercise_date: 1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.

SEC source: 0001470831-26-000636 · wk-form4_1782338786.xml · derivative · entry 7

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

F5 · derivative.exercise_date: 1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company.

SEC source: 0001470831-26-000636 · wk-form4_1782338786.xml · nonDerivative · entry 5

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,383

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000636 · wk-form4_1782338786.xml · nonDerivative · entry 4

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000636 · wk-form4_1782338786.xml · nonDerivative · entry 3

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,383

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000635 · wk-form4_1782338780.xml · nonDerivative · entry 4

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,259

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025.

SEC source: 0001470831-26-000636 · wk-form4_1782338786.xml · nonDerivative · entry 2

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,383

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.

SEC source: 0001470831-26-000630 · wk-form4_1782338749.xml · derivative · entry 2

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,277

Underlying: Common Stock · 5,277 shares

Expires 2036-06-21

F3 · derivative.exercise_date: The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

SEC source: 0001470831-26-000630 · wk-form4_1782338749.xml · nonDerivative · entry 1

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,579

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0001470831-26-000629 · wk-form4_1782338741.xml · derivative · entry 2

Hassan Fred · CIK 0001110744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,277

Underlying: Common Stock · 5,277 shares

Expires 2036-06-21

F3 · derivative.exercise_date: The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

SEC source: 0001470831-26-000629 · wk-form4_1782338741.xml · nonDerivative · entry 1

Hassan Fred · CIK 0001110744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,879

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0001470831-26-000631 · wk-form4_1782338755.xml · derivative · entry 2

DANIELS RONALD J · CIK 0001164475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,277

Underlying: Common Stock · 5,277 shares

Expires 2036-06-21

F3 · derivative.exercise_date: The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

SEC source: 0001470831-26-000631 · wk-form4_1782338755.xml · nonDerivative · entry 1

DANIELS RONALD J · CIK 0001164475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,981

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0001470831-26-000635 · wk-form4_1782338780.xml · derivative · entry 7

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,617

Underlying: Common Stock · 2,808 shares

Expires 2035-06-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors.

SEC source: 0001470831-26-000635 · wk-form4_1782338780.xml · derivative · entry 6

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,277

Underlying: Common Stock · 5,277 shares

Expires 2036-06-21

F4 · derivative.exercise_date: The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

SEC source: 0001470831-26-000635 · wk-form4_1782338780.xml · nonDerivative · entry 3

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,455

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025.

SEC source: 0001470831-26-000635 · wk-form4_1782338780.xml · nonDerivative · entry 2

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001470831-26-000635 · wk-form4_1782338780.xml · nonDerivative · entry 1

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,455

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.